CD27 and acute myeloid leukemia: The Marcela Maus laboratory evaluated the anti‐tumor activity of CD70 CAR‐T cells through the NSG Molm13 AML model and found that in co‐culture with AML, CD70‐CAR‐T cell activity was impaired by the soluble CD27 form was attenuated.60